Increased telomerase activity and hTERT expression in human salivary gland carcinomas

Oncology Letters

Volumn 2, Issue 5, 2011, Pages 845-850

  Shigeishi, Hideo ^a   Sugiyama, Masaru ^a   Tahara, Hidetoshi ^b   Ono, Shigehiro ^a   Bhawal, Ujjal Kumar ^c   Okura, Masaya ^d   Kogo, Mikihiko ^d   Shinohara, Masanori ^e   Shindoh, Masanobu ^f   Shintani, Satoru ^g   Hamakawa, Hiroyuki ^h   Takata, Takashi ^a   Kamata, Nobuyuki ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

^b Department of Medicine and Molecular Science Division of Integrated Medical Science   (Japan)

^c NIHON UNIVERSITY   (Japan)

^d OSAKA UNIVERSITY   (Japan)

^e KUMAMOTO UNIVERSITY   (Japan)

^f HOKKAIDO UNIVERSITY   (Japan)

^g SHOWA UNIVERSITY   (Japan)

^h EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Epidermal growth factor receptor; Human telomerase reverse transcriptase; Salivary gland carcinoma; Telomerase activity

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; KI 67 ANTIGEN; MESSENGER RNA; TELOMERASE; TELOMERASE REVERSE TRANSCRIPTASE;

ACINAR CELL CARCINOMA; ADENOID CYSTIC CARCINOMA; ADENOSQUAMOUS CARCINOMA; ARTICLE; CANCER GRADING; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ASSAY; HUMAN; HUMAN TISSUE; PLEOMORPHIC ADENOMA; PROTEIN EXPRESSION; SALIVARY GLAND CARCINOMA; WARTHIN TUMOR;

EID: 79960308407     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2011.354     Document Type: Article

References (32)

1. Hackett JA, Feldser DM and Greider CW: Telomere dysfunction increases mutation rate and genomic instability. Cell 106: 275-286, 2001.
2. Autexier C and Greider CW: Telomerase and cancer: revising the telomere hypothesis. Trends Biochem 21: 387-391, 1996.
3. Blackburn EH: Telomeres and telomerase: their mechanisms of action and the effects of altering their functions. FEBS Lett 579: 859-862, 2005.
4. Tahara H, Ide T, Afsgari C and Barrett JC: Involvement of telomere shortening and telomerase in cell aging and immortali-zation. Gann Monograph Cancer Res 49: 147-163, 2001.
5. Tahara H, Nakanishi T, Kitamoto M, Nakashio R, Shay JW and Tahara E: Telomerase activity in human liver tissues: Comparison between chronic liver disease and hepatocellular carcinomas. Cancer Res 55: 2734-2736, 2005.
6. Nakayama J, Tahara H, Tahara E, Saito M, Ito K, Nakamura H, Nakanishi T, Tahara E, Ide T and Ishikawa F: Telomerase activation by hTRT in human normal fibroblasts and hepatocellular carcinomas. Nat Gen 18: 65-68, 1998.
7. Cesare AJ and Reddel RR: Alternative lengthening of telomeres: models, mechanisms and implications. Nat Rev Genet 11: 319-330, 2010.
8. Shay JW and Bacchetti S: A survey of telomerase activity in human cancer. Eur J Cancer 33: 787-791, 1997.
9. Kim NW: Clinical implications of telomerase in cancer. Eur J Cancer 33: 781-786, 1997.
10. Miyoshi Y, Tsukinoki K, Imaizumi T, Yamada Y, Ishizaki T, Watanabe Y, Sasakura Y, Lin Y, Hosaka M and Kubota Y: Telomerase activity in oral cancer. Oral Oncol 35: 283-289, 1999.
11. Nakamura TM, Morin GB, Chapman KB, Weinrich SL, Andrews WH, Linger J, Harley CB and Cech TR: Telomerase catalytic subunit homologues from fission yeast and human. Science 277: 955-959, 1997.
12. Meyerson M, Counter CM, Eaton EN, et al: hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization. Cell 190: 785-795, 1997.
13. Feng J, Funk WD, Wang SS, WEinrich SL, Avilion AA, Chiu CP, Adams RR, Chang E, Allsopp RC and Yu J: The RNA component of human telomerase. Science 269: 1236-1241, 1995.
14. Chang JT, Chen Y, Yang H, Chen C and Cheng A: Differential regulation of telomerase activity by six telomerase subunits. Eur J Biochem 269: 3442-3450, 2002.
15. Fujimoto R, Kamata N, Yokoyama K, Ueda N, Satomura K, Hayashi E and Nagayama M: Expression of telomerase components in oral keratinocytes and squamous cell carcinomas. Oral Oncol 37: 132-140, 2000
16. Kim RH, Kim R, Chen W, Hu S, Shin KH, Park NH and Kang MK: Association of hsp90 to the hTERT promoter is necessary for hTERT expression in human oral cancer cells. Carcinogenesis 29: 2425-2431, 2008.
17. Seifert G and World Health Organization: International Histological Classification of Tumours: Histological typing of salivary gland tumours. 2nd edition. Springer, Berlin, pp111-113, 1992.
18. Normanno N, De Luca A, Bianco C, Strizzi L, Mancino M, Maiello MR, Carotenuto A, De Feo G, Caponigro F and Salomon DS: Epidermal growth factor receptor (EGFR) signaling in cancer. Gene 366: 2-16, 2006.
19. Shigeishi H, Higashikawa K, Hiraoka M, Fujimoto S, Mitani Y, Ohta K, Takechi M and Kamata N: Expression of epiregulin, a novel epidermal growth factor ligand associated with prognosis in human oral squamous cell carcinomas. Oncol Rep 19: 1557-1564, 2008.
20. Katopodi E, Patsouris E, Papanikolaou V, Karameris A, Douzinas E and Papanicolaou S: Immunohistochemical detection of epidermal growth factor and its receptor in salivary gland carcinomas. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 95: 266-268, 2003.
21. Wright WE, Shay JW and Piatyszek MA: Modifications of a telomeric repeat amplification protocol (TRAP) result in increased reliability, linearity and sensitivity. Nucleic Acids Res 23: 3794-3795, 1995.
22. Sumida T, Sogawa K, Hamakawa H, Sugita A, Tanioka H and Ueda N: Detection of telomerase activity in oral lesions. J Oral Pathol Med 27: 111-115, 1998.
23. Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-ΔΔC(T)) method. Methods 25: 402-408, 2001.
24. Liao J, Mitsuyasu T, Yamane K and Ohishi M: Telomerase activity in oral and maxillofacial tumors. Oral Oncol 36: 347-352, 2000.
25. Hiyama K, Hirai Y, Kyoizumi S, Akiyama M, Hiyama E, Piatyszek MA, Shay JW, Ishioka S and Yamakido M: Activation of telomerase in human lymphocytes and hematopoietic progenitor cells. J Immunol 155: 3711-3715, 1995.
26. Sumida T, Hamakawa H, Sogawa K, Sugita A, Tanioka H and Ueda N: Telomerase components as a diagnostic tool in human oral lesions. Int J Cancer 80: 1-4, 1999.
27. Takakura M and Kyo S: Expression of human telomerase subunits and correlation with telomerase activity in cervical cancer. Cancer Res 58: 1558-1561, 1998.
28. Kim ES, Khuri FR and Herbst RS: Epidermal growth factor receptor biology (IMC-C225). Curr Opin Oncol 13: 506-513, 2001.
29. Bargava R, Gerald WL, Li AR, Pan Q, Lal P, Ladanyi M and Chen B: EGFR gene amplification in breast cancer: correlation with epidermal growth factor receptor mRNA and protein expression and HER-2 status and absence of EGFR-activating mutations. Mod Pathol 18: 1027-1033, 2005.
30. Jimeno A, Tan AC, Coffa J, et al: Coordinated epidermal growth factor receptor pathway gene overexpression predicts epidermal growth factor receptor inhibitor sensitivity in pancreatic cancer. Cancer Res 68: 2841-2849, 2008.
31. Heeg S, Hirt N, Queisser A, et al: EGFR overexpression induces activation of telomerase via PI3K/AKT-mediated phosphorylation and transcriptional regulation through Hif1-alpha in a cellular model of oral-esophageal carcinogenesis. Cancer Sci 102: 351-360, 2011.
32. Chrysovergis A, Gorgoulis VG, Giotakis I, Tsiambas E, Karameris A, Kittas C and Kyroudi A: Simultaneous over activation of EGFR, telomerase (h TERT), and cyclin D1 correlates with advanced disease in larynx squamous cell carcinoma: a tissue microarray analysis. Med Oncol: Apr, 2010 (E-pub ahead of print).